genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Casgevy
GEN Edge
Going Public: Doudna’s Dream Team Launches Groundbreaking Sickle Cell Trial
Genome Editing
“Give Cas a Chance”: Fyodor Urnov Says He Wants a CRISPR Revolution
Drug Discovery
Pfizer Withdraws SCD Drug Oxbryta after EMA Discloses 16 Deaths in Trials
Artificial Intelligence
Electroporation in Cell Therapy
GEN Edge
A Story of Perseverance: An Interview with Matthew Porteus
Bioprocessing
Solvias to Perform Release Testing on CASGEVY
Bioprocessing
Charles River Achieves Milestone in Cell Therapy Manufacturing Deal with Vertex
Genome Editing
FDA Approves Casgevy, the First CRISPR Therapy, for Sickle Cell Disease
Bioprocessing
RoslinCT Will Manufacture World’s-First CRISPR-Based Therapy
Scroll Up
Scroll Up
